Article Details

Debunking Big Pharma's arguments for intellectual property rights

Retrieved on: 2021-02-07 14:24:07

Tags for this article:

Click the tags to see associated articles and topics

Debunking Big Pharma's arguments for intellectual property rights. View article details on hiswai:

Excerpt

They claimed that temporary TRIPS suspension "would jeopardise future medical innovation, making us more vulnerable to other diseases".

Article found on: thefinancialexpress.com.bd

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up